Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-01-31 to 2025-02-03
Current total value of award: $1299.31
Description: 4567116859!GRANIX 300 MCG/ML VIALML